NCCN, Esmo, and Chest Guidelines: Cancer Treatment Updates
Summary of CHEST guideline Development in Thoracic Oncology
This text details the rigorous process CHEST (the American College of Chest Physicians) uses to develop clinical practice guidelines, specifically highlighting its submission to thoracic oncology. Here’s a breakdown of the key aspects:
1. Foundation in GRADE Methodology:
CHEST guidelines are built upon the GRADE (Grading of Recommendations Assessment, Development, and Evaluation) framework – a globally recognized standard for evidence-based recommendations.
Guidelines are structured around PICO (Population, intervention, Comparator, Outcome) questions to ensure consistent evaluation of clinical scenarios. (Example given: Stage III lung cancer treatment options).
2. Systematic Review & Evidence Synthesis:
A thorough systematic literature review is conducted using databases like MEDLINE (via PubMed) and the Cochrane Library.
Duplicate screening,risk-of-bias assessments,and data abstraction are performed to ensure quality and accuracy.
Data collected includes participant characteristics, interventions, outcomes, funding, and Conflicts of Interest (COI).3. Proposal & Topic Selection:
CHEST issues an annual call for proposals for new guidelines. Proposals are prioritized based on:
Clinical importance
Relevance to CHEST members
Variability in current clinical practice (a key focus – guidelines target areas needing standardization)
Availability of sufficient data
4. Panel Formation & COI Policies:
Multidisciplinary panels are formed, including experts from pulmonology, thoracic surgery, oncology, etc.
CHEST has extremely strict COI policies: Panelists are expected to have no commercial relationships, or to divest from them within 12-24 months of guideline development. This prioritizes transparency and trust.
Panels are supported by methodologists to ensure methodological rigor.
5. Consensus & Drafting:
A modified Delphi process is used to achieve consensus, requiring 80% agreement.
Recommendations are categorized by strength and confidence in the supporting evidence.
* Transparency is maintained by documenting the rationale behind decisions and acknowledging uncertainties.
In essence, CHEST prioritizes a clear, self-reliant, and systematically rigorous approach to guideline development, aiming to provide clinicians with clear, evidence-based recommendations while acknowledging the limitations of the available data.